跳至主要内容
临床试验/NCT00618332
NCT00618332已完成不适用

Does the Response to a Nasal Decongestant Test Predict the Outcome to Treatment of Seasonal Allergic Rhinitis With Nasonex?

University of Chicago1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2008年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
1
主要终点
Global Assessment

研究概览

简要总结

We hypothesize that those patients with purely seasonal allergic rhinitis will decongest better than those subjects with another cause contributing to their symptoms. These latter patients will not improve as well on an intranasal steroid as those who decongest well, potentially explaining the 60% response rate in prior studies.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

1

Active Comparator

2 weeks of treatment

干预措施: mometasone furoate nasal spray (Drug)

2

Placebo Comparator

2 weeks of treatment

干预措施: placebo (Drug)

结局指标

主要结局

Global Assessment

时间窗: at week 2

Global Assessment: 3=significantly improved, 2=moderately improved, 1=mildly improved, 0=no change, -1=mildly worse, -2=moderately worse, and -3=significantly worse

次要结局

  • Changes in RQLQ: Overall(Baseline and 2 weeks)
  • Changes in RQLQ: Activity(Baseline and 2 weeks)
  • Changes in RQLQ: Sleep(Baseline and 2 weeks)
  • Changes in RQLQ: Non-Nasal/Eye(Baseline and 2 weeks)
  • Changes in RQLQ: Practical(Baseline and 2 weeks)
  • Changes in RQLQ: Nasal(Baseline and 2 weeks)
  • Changes in RQLQ: Emotional(Baseline and 2 weeks)
  • Changes in RQLQ: Eye(Baseline and 2 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验